🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06040827
Recruiting Observational

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension

NCT06040827 · tracked via the Priya Life Science USA tracker
Sponsor
Canary Medical
Phase
Observational
Started
2023-09-12
Last updated
2025-02-05

Condition(s) studied

Knee Osteoarthritis

Investigational drug(s) / intervention(s)

Total Knee Arthroplasty

Total Knee Arthroplasty: The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.

Study summary

The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion * Patient must be 18 years of age or older * Patient qualifies for primary total knee arthroplasty based on physical exam and medical history, including diagnosis of severe knee pain and disability due to osteoarthritis, limited to: * Mild or Moderate valgus, varus, or flexion deformities * Patient must be willing and able to complete the protocol required follow-up * Patient is indicated for a 58mm or 30mm tibial stem extension * Patient has participated in the study-related informed consent process * Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved informed consent * Patient has a platform-compatible personal computer located in their dwelling with appropriate wireless internet access and a USB port * Independent of study participation, patient is a candidate for commercially available Persona Personalized Knee System implanted in accordance with product labeling Exclusion * Simultaneous bilateral TKA * Staged bilateral TKA less than 6 months from indexed procedure * Patient is a current alcohol or drug abuser * Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.) * Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program * Patient has previous history of infection in the affected joint and/or a local or systemic infection that may affect the prosthetic joint * Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions * Patient with skeletal immaturity * Patient has insufficient bone stock on femoral or tibial surfaces * Patient with Neuropathic Arthropathy * Patient has osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb * Patient has severe instability secondary to the absence of collateral ligament integrity. * Patient has a stable, painless arthrodesis in a satisfactory functional position * Patient has rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin * Patient has a known or suspected sensitivity to one or more of the implant materials * Patient is undergoing procedures or treatments using ionizing radiation * Patients with known symptomatic foot, hip, or spinal injuries and/or conditions that could affect gait

Primary outcome measure(s)

Trial sites (7)

FacilityCityRegionStatus
Ozark Orthopaedics Fayetteville Arkansas Recruiting
Foundation For Orthopaedic Research and Education Tampa Florida Recruiting
Northside Hospital Atlanta Georgia Recruiting
South Bend Orthopaedics South Bend Indiana Recruiting
Cleveland Clinic Cleveland Ohio Recruiting
JIS Research Institute New Albany Ohio Enrolling By Invitation
Carolina Orthopaedic & Neurosurgical Associates Spartanburg South Carolina Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06040827 on ClinicalTrials.gov ↗ ← All trials in the USA